Technical Analysis for SCLX - Scilex Holding Company
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.56 | -13.29% | -0.09 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Lower Bollinger Band Walk | Weakness | -13.29% | |
Inside Day | Range Contraction | -13.29% | |
Wide Bands | Range Expansion | -13.29% | |
Oversold Stochastic | Weakness | -13.29% | |
Lower Bollinger Band Walk | Weakness | -11.09% |
Alert | Time |
---|---|
2x Volume Pace | about 20 hours ago |
1.5x Volume Pace | about 20 hours ago |
Down 5% | about 20 hours ago |
Down 3% | about 20 hours ago |
Fell Below Lower Bollinger Band | about 20 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: Unknown
Scilex Holding Company Description
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXAâ„¢, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Pain Organ Systems Pharmaceutical Products Opioids Chronic Pain Pain Management Acute Pain Acute And Chronic Pain Palliative Care Nociception
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.63 |
52 Week Low | 0.5377 |
Average Volume | 2,194,399 |
200-Day Moving Average | 1.26 |
50-Day Moving Average | 0.89 |
20-Day Moving Average | 0.85 |
10-Day Moving Average | 0.73 |
Average True Range | 0.11 |
RSI (14) | 29.08 |
ADX | 22.89 |
+DI | 16.96 |
-DI | 28.78 |
Chandelier Exit (Long, 3 ATRs) | 0.81 |
Chandelier Exit (Short, 3 ATRs) | 0.87 |
Upper Bollinger Bands | 1.16 |
Lower Bollinger Band | 0.54 |
Percent B (%b) | 0.03 |
BandWidth | 72.08 |
MACD Line | -0.09 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.0355 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.66 | ||||
Resistance 3 (R3) | 0.67 | 0.64 | 0.65 | ||
Resistance 2 (R2) | 0.64 | 0.62 | 0.64 | 0.64 | |
Resistance 1 (R1) | 0.60 | 0.60 | 0.59 | 0.60 | 0.64 |
Pivot Point | 0.58 | 0.58 | 0.57 | 0.57 | 0.58 |
Support 1 (S1) | 0.54 | 0.55 | 0.52 | 0.53 | 0.49 |
Support 2 (S2) | 0.51 | 0.54 | 0.51 | 0.49 | |
Support 3 (S3) | 0.47 | 0.51 | 0.48 | ||
Support 4 (S4) | 0.47 |